Related Experiment Video
Updated: Mar 26, 2026
Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Mutant p53 Drives Cancer by Subverting Multiple Tumor Suppression Pathways
Sue Haupt1, Dinesh Raghu2, Ygal Haupt3
1Tumour Suppression Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Department of Pathology, The University of Melbourne, Parkville, VIC, Australia.
Abstract:
The tumor suppressor p53 normally acts as a brake to halt damaged cells from perpetrating their genetic errors into future generations. If p53 is disrupted by mutation, it may not only lose these corrective powers, but counterproductively acquire new capacities that drive cancer. A newly emerging manner in which mutant p53 executes its cancer promoting functions is by harnessing key proteins, which normally partner with its wild type, tumor-inhibiting counterpart. In association with the subverted activities of these protein partners, mutant p53 is empowered to act across multiple fundamental cellular pathways (regulating cell division and metabolism) and corrupt them to become cancer promoting.
Insights
Mutant tumor suppressor p53 loses its cancer-preventing ability and gains cancer-driving functions. It hijacks normal protein partners to disrupt cell division and metabolism, promoting tumor growth.
Area of Science:
- Molecular Biology
- Cancer Research
- Cellular Pathway Analysis
Background:
- The tumor suppressor p53 is crucial for preventing genetic errors in cells.
- Mutations in p53 can lead to loss of its tumor-suppressing function and acquisition of cancer-promoting capabilities.
Purpose of the Study:
- To investigate the novel mechanisms by which mutant p53 drives cancer progression.
- To understand how mutant p53 interacts with protein partners to subvert cellular functions.
Main Methods:
- Analysis of protein-protein interactions involving wild-type and mutant p53.
- Investigation of cellular pathway regulation in the presence of mutant p53.
Main Results:
- Mutant p53 actively recruits and subverts the functions of normal p53 protein partners.
- These interactions enable mutant p53 to corrupt fundamental cellular pathways, including cell division and metabolism.
- The corrupted pathways contribute to the promotion and progression of cancer.
Conclusions:
- Mutant p53 actively promotes cancer by hijacking normal cellular machinery.
- Targeting the aberrant interactions of mutant p53 with its protein partners may offer new therapeutic strategies for cancer treatment.
Related Concept Videos
02:23Abnormal Proliferation
01:19Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:12Loss of Tumor Suppressor Gene Functions